You are here: Home » News-IANS » Health-Medicine
Business Standard

Traditional drugs being developed for vector borne diseases

IANS  |  New Delhi 

The central government on Friday said that traditional medicines are being developed for prevention and management of vector borne diseases.

Pre-clinical studies for AYUSH PJ7 -- a new drug for dengue -- have been completed, Minister of State for Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) Shripad Yasso Naik said in a written reply to the Lok Sabha.

The minister said that four research councils set up by the Centre are involved in research activities, inter-alia including development and formulation of new drugs.

These research councils are the Central Council for Research in Ayurvedic Sciences (CCRAS), Central Council for Research in Unani Medicine (CCRUM), Central Council for Research in Siddha (CCRS) and Central Council for Research in Homoeopathy (CCRH).

"CCRAS has recently developed AYUSH PJ7 for dengue and AYUSH SL for filarisis. Pre-clinical studies for both the new drugs has been completed," Naik said.

The CCRAS has formulated Ayush 64, a poly herbal, anti-malarial drug, he said and added that it has made deliberations to conduct clinical studies with Indian Council of Medical Research (ICMR) to counter diseases like dengue.

The minister said that CCRUM has made observational studies on the efficacy of some Unani drugs in the vector borne diseases, like malaria, filarisis and Kala Azar which has showed significant therapeutic effects in subsiding different signs and symptoms in these conditions.

"Clinical management studies on dengue, Japanese encephalitis and acute lymphadenitis due to filariasis have already been conducted by CCRH," he added.

--IANS

and/vgu/vt

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Traditional drugs being developed for vector borne diseases

The central government on Friday said that traditional medicines are being developed for prevention and management of vector borne diseases.

The central government on Friday said that traditional medicines are being developed for prevention and management of vector borne diseases.

Pre-clinical studies for AYUSH PJ7 -- a new drug for dengue -- have been completed, Minister of State for Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) Shripad Yasso Naik said in a written reply to the Lok Sabha.

The minister said that four research councils set up by the Centre are involved in research activities, inter-alia including development and formulation of new drugs.

These research councils are the Central Council for Research in Ayurvedic Sciences (CCRAS), Central Council for Research in Unani Medicine (CCRUM), Central Council for Research in Siddha (CCRS) and Central Council for Research in Homoeopathy (CCRH).

"CCRAS has recently developed AYUSH PJ7 for dengue and AYUSH SL for filarisis. Pre-clinical studies for both the new drugs has been completed," Naik said.

The CCRAS has formulated Ayush 64, a poly herbal, anti-malarial drug, he said and added that it has made deliberations to conduct clinical studies with Indian Council of Medical Research (ICMR) to counter diseases like dengue.

The minister said that CCRUM has made observational studies on the efficacy of some Unani drugs in the vector borne diseases, like malaria, filarisis and Kala Azar which has showed significant therapeutic effects in subsiding different signs and symptoms in these conditions.

"Clinical management studies on dengue, Japanese encephalitis and acute lymphadenitis due to filariasis have already been conducted by CCRH," he added.

--IANS

and/vgu/vt

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Traditional drugs being developed for vector borne diseases

The central government on Friday said that traditional medicines are being developed for prevention and management of vector borne diseases.

Pre-clinical studies for AYUSH PJ7 -- a new drug for dengue -- have been completed, Minister of State for Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) Shripad Yasso Naik said in a written reply to the Lok Sabha.

The minister said that four research councils set up by the Centre are involved in research activities, inter-alia including development and formulation of new drugs.

These research councils are the Central Council for Research in Ayurvedic Sciences (CCRAS), Central Council for Research in Unani Medicine (CCRUM), Central Council for Research in Siddha (CCRS) and Central Council for Research in Homoeopathy (CCRH).

"CCRAS has recently developed AYUSH PJ7 for dengue and AYUSH SL for filarisis. Pre-clinical studies for both the new drugs has been completed," Naik said.

The CCRAS has formulated Ayush 64, a poly herbal, anti-malarial drug, he said and added that it has made deliberations to conduct clinical studies with Indian Council of Medical Research (ICMR) to counter diseases like dengue.

The minister said that CCRUM has made observational studies on the efficacy of some Unani drugs in the vector borne diseases, like malaria, filarisis and Kala Azar which has showed significant therapeutic effects in subsiding different signs and symptoms in these conditions.

"Clinical management studies on dengue, Japanese encephalitis and acute lymphadenitis due to filariasis have already been conducted by CCRH," he added.

--IANS

and/vgu/vt

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard